1. Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors.
- Author
-
Starosyla, Sergiy A., Volynets, Galyna P., Protopopov, Mykola V., Bdzhola, Volodymyr G., Pashevin, Denis O., Polishchuk, Valentyna O., Kozak, Taisiia O., Stroi, Dmytro O., Dosenko, Victor E., and Yarmoluk, Sergiy M.
- Subjects
MOLECULAR dynamics ,MOLECULAR docking ,ADULT respiratory distress syndrome ,CHEMICAL models ,MOLECULES ,PROTEIN kinase C - Abstract
Protein kinase Cβ (PKCβ) is considered as an attractive molecular target for the treatment of COVID-19-related acute respiratory distress syndrome (ARDS). Several classes of inhibitors have been already identified. In this article, we developed and validated ligand-based PKCβ pharmacophore models based on the chemical structures of the known inhibitors. The most accurate pharmacophore model, which correctly predicted more than 70% active compounds of test set, included three aromatic pharmacophore features without vectors, one hydrogen bond acceptor pharmacophore feature, one hydrophobic pharmacophore feature and 158 excluded volumes. This pharmacophore model was used for virtual screening of compound collection in order to identify novel potent PKCβ inhibitors. Also, molecular docking of compound collection was performed and 28 compounds which were selected simultaneously by two approaches as top-scored were proposed for further biological research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF